NAV | $16.29 | Daily Change | -$0.02 | -0.12% |
Market Price | $16.12 | Daily Change | -$0.07 | -0.43% |
CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.
In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.
The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.
Inception Date | 12/07/18 |
Total Expense Ratio | 0.65% |
Net Assets | $9.77 million |
NAV | $16.29 |
Fact Sheet |
The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).
The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.
Ticker | CHIH |
Bloomberg Index Ticker | NU722071 |
CUSIP | 37954Y541 |
ISIN | US37954Y5419 |
Primary Exchange | NYSE Arca |
Shares Outstanding | 600,002 |
Number of Holdings | 81 |
30-Day Median Bid-Ask Spread | 1.34% |
30-Day SEC Yield | 0.37% |
Distribution Frequency | Semi-Annually |
NAV | $16.29 | Daily Change | -$0.02 | -0.12% |
Market Price | $16.12 | Daily Change | -$0.07 | -0.43% |
As of recent (12/31/22)
As of recent (12/31/22)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | -22.67% | -23.41% | -22.12% |
3 Years | -1.61% | -1.99% | -0.91% |
Since Inception | 3.03% | 2.74% | 3.78% |
1 Year | -10.75% | -11.37% | -10.11% |
3 Years | -3.65% | -3.87% | -2.96% |
Since Inception | 2.79% | 2.66% | 3.54% |
Year-to-Date | -22.67% | -23.41% | -22.12% |
1 Month | 4.39% | 1.62% | 4.43% |
3 Months | 25.30% | 24.81% | 25.66% |
Since Inception | 12.90% | 11.61% | 16.29% |
Year-to-Date | -0.48% | 0.12% | -0.37% |
1 Month | -8.67% | -9.46% | -8.61% |
3 Months | 3.89% | 1.75% | 4.04% |
Since Inception | 12.36% | 11.75% | 15.86% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
8.56 | 6160 HK | BEIGENE LTD | BGDY260 | 16.98 | 49,239 | 836,154.08 |
8.39 | 2269 HK | WUXI BIOLOGICS CAYMAN INC | BL6B9P1 | 6.46 | 126,880 | 819,498.32 |
6.91 | 1093 HK | CSPC PHARMACEUTI | 6191997 | 0.99 | 684,808 | 675,237.77 |
4.89 | 1177 HK | SINO BIOPHARMACEUTICAL | B00XSF9 | 0.56 | 848,300 | 477,659.78 |
4.44 | 1801 HK | INNOVENT BIOLOGICS INC | BGR6KX5 | 4.97 | 87,400 | 434,233.16 |
3.34 | 1099 HK | SINOPHARM GROUP CO-H | B3ZVDV0 | 2.89 | 112,900 | 326,487.64 |
3.28 | 1066 HK | SHANDONG WEIG-H | 6742340 | 1.55 | 207,300 | 320,601.04 |
3.11 | 2359 HK | WUXI APPTEC CO LTD-H | BGHH0L6 | 10.45 | 29,056 | 303,526.50 |
2.82 | 300760 C2 | SHENZHEN MINDR-A | BHQK864 | 45.75 | 6,017 | 275,293.87 |
2.49 | 1548 HK | GENSCRIPT BIOTECH CORP | BD9Q2J2 | 2.45 | 99,471 | 243,301.43 |
2.35 | ZLAB | ZAI LAB LTD-ADR | BD9GVY0 | 31.46 | 7,306 | 229,846.76 |
2.20 | 6078 HK | HYGEIA HEALTHCAR | BMX09H0 | 7.50 | 28,600 | 214,599.28 |
2.15 | 600276 C1 | JIANGSU HENGRU-A | BP3R369 | 6.26 | 33,572 | 210,149.74 |
1.95 | 867 HK | CHINA MEDICAL SY | B6WY993 | 1.58 | 119,900 | 190,014.40 |
1.93 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 1.79 | 105,300 | 188,339.94 |
1.83 | LEGN | LEGEND BIOTECH CORP-ADR | BMX9K07 | 43.82 | 4,080 | 178,785.60 |
1.80 | 300015 C2 | AIER EYE HSPTL-A | BD5CLQ4 | 4.50 | 39,048 | 175,859.64 |
1.64 | 603259 C1 | WUXI APPTEC CO LTD-A | BHWLWV4 | 11.78 | 13,624 | 160,450.47 |
1.55 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 2.61 | 58,100 | 151,361.84 |
1.54 | 9926 HK | AKESO INC - B | BLFJ7Y1 | 5.37 | 28,000 | 150,349.69 |
1.47 | 2607 HK | SHANGHAI PHARM-H | B4Q4CJ6 | 1.92 | 74,700 | 143,315.29 |
1.45 | 600436 C1 | ZHANGZHOU PIEN-A | BP3R7Z6 | 41.56 | 3,406 | 141,553.37 |
1.43 | 570 HK | TRAD CHI MED | 6971779 | 0.54 | 260,600 | 139,434.63 |
1.39 | 1530 HK | 3SBIO INC | BY9D3L9 | 1.00 | 136,700 | 136,182.78 |
1.37 | 2196 HK | FOSUN PHARMA-H | B8XBQ96 | 2.82 | 47,300 | 133,469.43 |
1.24 | 3320 HK | CHINA RESOURCES | BYNGG26 | 0.89 | 136,500 | 121,028.83 |
1.15 | 3347 HK | HANGZHOU TIGER-H | BMZC7F8 | 10.48 | 10,720 | 112,393.59 |
1.13 | 300122 C2 | CHONGQING ZHIF-A | BD5CJY8 | 12.67 | 8,733 | 110,625.39 |
0.94 | 3759 HK | PHARMARON BEIJ-H | BK72QD3 | 5.24 | 17,575 | 92,020.40 |
0.91 | 000538 C2 | YUNNAN BAIYAO-A | BD5CP95 | 7.89 | 11,314 | 89,228.67 |
0.89 | 300896 C2 | IMEIK TECHNOLO-A | BNR4MY3 | 75.51 | 1,156 | 87,286.98 |
0.76 | 000963 C2 | HUADONG MEDICINE CO LTD-A | BD5CM94 | 6.37 | 11,611 | 73,975.59 |
0.66 | 600196 C1 | SHANGHAI FOSUN-A | BP3R3M5 | 4.71 | 13,574 | 63,960.58 |
0.60 | 600085 C1 | BEIJING TONGRENTANG CO-A | BP3R5C9 | 7.44 | 7,900 | 58,803.96 |
0.60 | 603392 C1 | BEIJING WANTAI-A | BMXTWX4 | 17.68 | 3,290 | 58,158.33 |
0.58 | 600332 C1 | GUANGZHOU BAIY-A | BP3R4Q6 | 4.65 | 12,159 | 56,508.27 |
0.58 | 000661 C2 | CHANGCHUN HIGH-A | BD5CDB3 | 24.59 | 2,290 | 56,313.98 |
0.54 | 002294 C2 | SHENZHEN SALUBRIS PHARM-A | BD5CM05 | 5.19 | 10,200 | 52,910.45 |
0.53 | 300142 C2 | WALVAX BIOTECHNOLOGY CO-A | BD5CG36 | 5.37 | 9,700 | 52,095.53 |
0.52 | 002001 C2 | ZHEJIANG NHU CO LTD-A | BD5CH66 | 2.61 | 19,568 | 51,010.89 |
0.52 | 601607 C1 | SHANG PHARM -A | BP3R4Z5 | 3.02 | 16,700 | 50,369.61 |
0.51 | 300347 C2 | HANGZHOU TIGER-A | BD5CCK5 | 15.59 | 3,216 | 50,146.13 |
0.51 | 002422 C2 | SICHUAN KELUN-A | BD5CL08 | 3.97 | 12,500 | 49,657.82 |
0.49 | 300759 C2 | PHARMARON BEIJ-A | BK4XYC4 | 8.56 | 5,600 | 47,910.92 |
0.47 | 002603 C2 | SHIJIAZHUANG Y-A | BD5CHJ9 | 4.20 | 11,027 | 46,329.69 |
0.47 | 000999 C2 | CHINA RESOURCE-A | BD5CL42 | 7.88 | 5,800 | 45,725.10 |
0.47 | 000423 C2 | DONG-E-E-JIAOCO LTD-A | BD5CM61 | 6.71 | 6,800 | 45,598.35 |
0.46 | 600998 C1 | JOINTOWN PHARMACEUTICAL-A | BP3R541 | 2.18 | 20,770 | 45,247.23 |
0.43 | 300832 C2 | SHENZHEN NEW-A | BMXTX20 | 8.34 | 5,000 | 41,692.03 |
0.42 | 002821 C2 | ASYMCHEM LABOR-A | BD6V5C4 | 20.29 | 2,038 | 41,357.05 |
0.42 | 600079 C1 | HUMANWELL HEAL-A | BP3R712 | 3.81 | 10,700 | 40,733.35 |
0.41 | 002044 C2 | MEINIAN ONEHEA-A | BD73L10 | 0.98 | 41,020 | 40,017.16 |
0.41 | 002252 C2 | SHANGHAI RAAS -A | BD5CPJ5 | 0.92 | 43,400 | 39,855.94 |
0.41 | 300003 C2 | LEPU MEDICAL TECHNOLOGY-A | BD5CM16 | 3.45 | 11,501 | 39,649.02 |
0.40 | 603882 C1 | GUANGZHOU KING-A | BFYX689 | 12.60 | 3,100 | 39,069.19 |
0.39 | 002007 C2 | HUALAN BIOLOGI-A | BD5CL19 | 3.29 | 11,670 | 38,382.70 |
0.39 | 600763 C1 | TOPCHOICE MEDI-A | BYYFJH8 | 19.36 | 1,980 | 38,341.41 |
0.37 | 603858 C1 | SHANDONG BUCHA-A | BYW5NC3 | 2.90 | 12,587 | 36,468.54 |
0.35 | 688363 C1 | BLOOMAGE BIOTE-A | BP91NT8 | 16.16 | 2,097 | 33,888.42 |
0.34 | 688180 C1 | SHANGHAI JUNSH-A | BLCD7F7 | 7.21 | 4,642 | 33,490.58 |
0.34 | 300601 C2 | SHENZHEN KANGT-A | BFY8HT2 | 4.75 | 7,048 | 33,458.26 |
0.32 | 603456 C1 | ZHEJIANG JIUZH-A | BMQBVL8 | 5.47 | 5,700 | 31,173.08 |
0.31 | 300595 C2 | OVCTEK CHINA INC-A | BHQPSJ2 | 4.82 | 6,224 | 29,984.84 |
0.30 | 600521 C1 | ZHEJIANG HUAHA-A | BP3RBR6 | 2.91 | 10,010 | 29,134.31 |
0.30 | 002223 C2 | JIANGSU YUYUE-A | BD5CJM6 | 4.46 | 6,500 | 28,997.38 |
0.29 | 000739 C2 | APELOA PHARMA-A | BD5LY17 | 3.28 | 8,500 | 27,894.20 |
0.28 | 300357 C2 | ZHEJIANG WOLWO-A | BFY8GY0 | 7.32 | 3,723 | 27,242.60 |
0.27 | 300676 C2 | BGI GENOMICS CO LTD-A | BFY8H58 | 8.72 | 3,033 | 26,460.58 |
0.27 | 603707 C1 | NANJING KING-F-A | BF2DZL7 | 2.33 | 11,236 | 26,224.72 |
0.27 | 300529 C2 | JAFRON BIOMEDI-A | BFY8H03 | 4.48 | 5,800 | 25,993.71 |
0.27 | 600380 C1 | JOINCARE PHARM-A | BP3RBV0 | 1.88 | 13,800 | 25,913.02 |
0.26 | 600566 C1 | HUBEI JUMPCAN -A | BS7K3N2 | 4.17 | 6,200 | 25,830.87 |
0.26 | 300558 C2 | BETTA PHARMACE-A | BD6QWL7 | 8.19 | 3,120 | 25,548.97 |
0.26 | 688301 C1 | IRAY TECHNOLOGY CO LTD-A | BQ3RXC2 | 52.83 | 482 | 25,463.80 |
0.25 | 300363 C2 | PORTON PHARMA -A | BD5LZ92 | 6.16 | 4,000 | 24,639.67 |
0.25 | 603127 C1 | JOINN LABORATO-A | BK94819 | 7.97 | 3,040 | 24,229.38 |
0.25 | 000513 C2 | LIVZON PHARM-A | BD5CQ25 | 5.11 | 4,700 | 24,001.09 |
0.24 | 002030 C2 | DAAN GENE CO LTD-A | BD5CKW3 | 2.31 | 10,160 | 23,445.06 |
0.23 | 600056 C1 | CHINA MEHECO CO LTD -A | BP3R8X1 | 2.07 | 11,000 | 22,817.66 |
0.13 | 688202 C1 | SHANGHAI MEDICILON INC-A | BNR4NV7 | 24.00 | 547 | 13,125.62 |
0.10 | 603658 C1 | AUTOBIO DIAGNO-A | BYW5N89 | 8.68 | 1,100 | 9,553.08 |
0.04 | CASH | 1.00 | 4,127 | 4,127.41 | ||
0.00 | HONG KONG DOLLAR | 0.00 | 0 | 0.00 | ||
0.00 | CHINESE YUAN RENMINBI | 0.15 | -1 | -0.09 |
Return on Equity | 9.70% | |
Weighted Avg. Market Cap | 14,032 M | |
2022 | 2023 | |
Price-to-earnings | 42.58 | 28.60 |
Price-to-book value | 2.87 | 2.68 |
Source: AltaVista Research, LLC
Versus | Beta |
---|---|
S&P 500 | 0.52 |
MSCI EAFE | 0.69 |
MSCI Emg. Mkts | 0.98 |
Standard Deviation | 32.00% |
Source: AltaVista Research, LLC
Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.